Procaspase combination therapy for glioblastoma

Michael Kevin Handley; Avadhut Joshi; Timothy M Fan; Paul J Hergenrother; Howard S Roth; Mark John Gilbert; Rachel C Botham; Gregory J Riggins; Andrea Deering

Procaspase combination therapy for glioblastoma

Michael Kevin Handley (Inventor), Avadhut Joshi (Inventor), Timothy M Fan (Inventor), Paul J Hergenrother (Inventor), Howard S Roth (Inventor), Mark John Gilbert (Inventor), Rachel C Botham (Inventor), Gregory J Riggins (Inventor), Andrea Deering (Inventor)

Research output: Patent

Abstract

The invention provides compositions and methods for the induction of cell death, for example, cancer cell death. Combinations of compounds and related methods of use are disclosed, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells. The disclosed drug combinations can have lower neurotoxicity effects than other compounds and combinations of compounds.

Original language	English (US)
U.S. patent number	9421202
Filing date	3/6/13
State	Published - Aug 23 2016

Library availability

Discover UIUC Full Text

Cite this

@misc{822f8ac2329a436e88bc0a34bc52a854,

title = "Procaspase combination therapy for glioblastoma",

abstract = "The invention provides compositions and methods for the induction of cell death, for example, cancer cell death. Combinations of compounds and related methods of use are disclosed, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells. The disclosed drug combinations can have lower neurotoxicity effects than other compounds and combinations of compounds.",

author = "Handley, {Michael Kevin} and Avadhut Joshi and Fan, {Timothy M} and Hergenrother, {Paul J} and Roth, {Howard S} and Gilbert, {Mark John} and Botham, {Rachel C} and Riggins, {Gregory J} and Andrea Deering",

year = "2016",

month = aug,

day = "23",

language = "English (US)",

type = "Patent",

note = "9421202",

}

TY - PAT

T1 - Procaspase combination therapy for glioblastoma

AU - Handley, Michael Kevin

AU - Joshi, Avadhut

AU - Fan, Timothy M

AU - Hergenrother, Paul J

AU - Roth, Howard S

AU - Gilbert, Mark John

AU - Botham, Rachel C

AU - Riggins, Gregory J

AU - Deering, Andrea

PY - 2016/8/23

Y1 - 2016/8/23

N2 - The invention provides compositions and methods for the induction of cell death, for example, cancer cell death. Combinations of compounds and related methods of use are disclosed, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells. The disclosed drug combinations can have lower neurotoxicity effects than other compounds and combinations of compounds.

AB - The invention provides compositions and methods for the induction of cell death, for example, cancer cell death. Combinations of compounds and related methods of use are disclosed, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells. The disclosed drug combinations can have lower neurotoxicity effects than other compounds and combinations of compounds.

M3 - Patent

M1 - 9421202

Y2 - 2013/03/06

ER -

Procaspase combination therapy for glioblastoma

Abstract

Library availability

Fingerprint

Cite this